All Stories

  1. Melatonin receptors in diabetes: A potential new therapeutical target?

    Article • European Journal of Pharmacology, December 2014, Elsevier

    Dr Moshe Laudon

  2. Therapeutic Effects of Melatonin Receptor Agonists on Sleep and Comorbid Disorders

    Article • International Journal of Molecular Sciences, September 2014, MDPI AG

    Dr Moshe Laudon

  3. Melatonin rescues 3T3-L1 adipocytes from FFA-induced insulin resistance by inhibiting phosphorylation of IRS-1 on Ser307

    Article • Biochimie, August 2014, Elsevier

    Dr Moshe Laudon

  4. Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer’s disease: a 6-month, randomized, placebo-controlled, multicenter trial

    Article • Clinical Interventions in Aging, June 2014, Taylor & Francis

    Dr Moshe Laudon, Dr Alan G Wade, Professor Nava Zisapel

  5. Piromelatine exerts antinociceptive effect via melatonin, opioid, and 5HT1A receptors and hypnotic effect via melatonin receptors in a mouse model of neuropathic pain

    Article • Psychopharmacology, April 2014, Springer Science + Business Media

    Dr Moshe Laudon

  6. Piromelatine, a novel melatonin receptor agonist, stabilizes metabolic profiles and ameliorates insulin resistance in chronic sleep restricted rats

    Article • European Journal of Pharmacology, March 2014, Elsevier

    Dr Moshe Laudon

  7. Piromelatine decreases triglyceride accumulation in insulin resistant 3T3-L1 adipocytes: Role of ATGL and HSL

    Article • Biochimie, August 2013, Elsevier

    Dr Moshe Laudon

  8. A novel melatonin agonist Neu-P11 facilitates memory performance and improves cognitive impairment in a rat model of Alzheimer' disease

    Article • Hormones and Behavior, June 2013, Elsevier

    Dr Moshe Laudon

  9. Efficacy of prolonged-release melatonin versus placebo in a three-week treatment of diabetic patients suffering from insomnia

    Article • January 2013, Springer Science + Business Media

    Dr Moshe Laudon

  10. Cardiovascular effects of melatonin receptor agonists

    Article • Expert Opinion on Investigational Drugs, August 2012, Informa Healthcare

    Dr Moshe Laudon, Dr Ludovit Paulis

  11. Effect of melatonin on nocturnal blood pressure: meta-analysis of randomized controlled trials

    Article • Vascular Health and Risk Management, September 2011, Taylor & Francis

    Dr Moshe Laudon, Professor Nava Zisapel

  12. Prolonged-release melatonin for insomnia – an open-label long-term study of efficacy, safety, and withdrawal

    Article • Therapeutics and Clinical Risk Management, July 2011, Taylor & Francis

    Dr Moshe Laudon, Patrick LEMOINE

  13. Prolonged-Release Melatonin for Children With Neurodevelopmental Disorders

    Article • Pediatric Neurology, July 2011, Elsevier

    Dr Moshe Laudon

  14. The Effects of Neu-P11 on memory performance in NaN3 induced posterior cingulate cortex hypometabolism

    Article • Alzheimer s & Dementia, July 2011, Elsevier

    Dr Moshe Laudon

  15. Neu-P11, a melatonin/serotonin receptors agonist, protects CA1 pyramidal neurons and cognitive performance in a rat model of Alzheimer, disease

    Article • Alzheimer s & Dementia, July 2011, Elsevier

    Dr Moshe Laudon

  16. Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response

    Article • Current Medical Research and Opinion, November 2010, Informa Healthcare

    Dr Moshe Laudon

  17. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety

    Article • BMC Medicine, August 2010, Springer Science + Business Media

    Dr Moshe Laudon

  18. Antidepressant- and anxiolytic effects of the novel melatonin agonist Neu-P11 in rodent models

    Article • Acta Pharmacologica Sinica, June 2010, Springer Science + Business Media

    Dr Moshe Laudon

  19. NEU-P11, a novel melatonin agonist, inhibits weight gain and improves insulin sensitivity in high-fat/high-sucrose-fed rats

    Article • Pharmacological Research, April 2009, Elsevier

    Dr Moshe Laudon

  20. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects

    Article • Journal of Sleep Research, December 2007, Wiley

    Dr Moshe Laudon

  21. Efficacy of prolonged release melatonin in insomnia patients aged 55–80 years: quality of sleep and next-day alertness outcomes

    Article • Current Medical Research and Opinion, September 2007, Informa Healthcare

    Dr Moshe Laudon

  22. Low melatonin production in infants with a life-threatening event

    Article • Developmental Medicine & Child Neurology, February 2007, Wiley

    Dr Moshe Laudon

  23. Melatonin treatment of non-epileptic myoclonus in children

    Article • Developmental Medicine & Child Neurology, February 2007, Wiley

    Dr Moshe Laudon

  24. Melatonin Reduces Night Blood Pressure in Patients with Nocturnal Hypertension

    Article • The American Journal of Medicine, October 2006, Elsevier

    Dr Moshe Laudon

  25. A Comparison of Visual Analog Scale and Categorical Ratings in Assessing the Patient’s Estimate of Sleep Quality

    Article • January 2006, Springer Science + Business Media

    Dr Moshe Laudon

  26. Nocturnal 6-sulfatoxymelatonin excretion in insomnia and its relation to the response to melatonin replacement therapy

    Article • The American Journal of Medicine, January 2004, Elsevier

    Dr Moshe Laudon

  27. Effect of controlled-release melatonin on sleep quality, mood, and quality of life in subjects with seasonal or weather-associated changes in mood and behaviour

    Article • European Neuropsychopharmacology, May 2003, Elsevier

    Professor Timo Partonen, Dr Moshe Laudon

  28. Cross-cultural validation of the Leeds sleep evaluation questionnaire (LSEQ) in insomnia patients

    Article • Human Psychopharmacology Clinical and Experimental, January 2003, Wiley

    Dr Moshe Laudon

  29. Massage Therapy by Mothers Enhances the Adjustment of Circadian Rhythms to the Nocturnal Period in Full-Term Infants

    Article • Journal of Developmental & Behavioral Pediatrics, December 2002, Wolters Kluwer Health

    Dr Moshe Laudon

  30. Melatonin production in infants

    Article • Pediatric Neurology, May 2002, Elsevier

    Dr Moshe Laudon

  31. Melatonin rhythms in stroke patients

    Article • Neuroscience Letters, February 2002, Elsevier

    Dr Moshe Laudon

  32. Melatonin Production in Healthy Infants: Evidence for Seasonal Variations

    Article • Pediatric Research, January 2001, Springer Science + Business Media

    Dr Moshe Laudon

  33. First-Night Effect of Melatonin Treatment in Patients With Chronic Schizophrenia

    Article • Journal of Clinical Psychopharmacology, December 2000, Wolters Kluwer Health

    Dr Moshe Laudon

  34. Clinical trials of controlled-release melatonin in children with sleep-wake cycle disorders

    Article • Journal of Pineal Research, August 2000, Wiley

    Dr Moshe Laudon

  35. Low melatonin production in infants with a life-threatening event

    Article • Developmental Medicine & Child Neurology, July 2000, Wiley

    Dr Moshe Laudon

  36. Melatonin Improves Sleep Quality of Patients With Chronic Schizophrenia

    Article • The Journal of Clinical Psychiatry, May 2000, Physicians Postgraduate Press, Inc

    Dr Moshe Laudon

  37. Facilitation of Benzodiazepine Discontinuation by Melatonin

    Article • Archives of Internal Medicine, November 1999, American Medical Association (AMA)

    Dr Moshe Laudon

  38. Melatonin Production in Infants At High Risk for Sids

    Article • Pediatric Research, May 1999, Springer Science + Business Media

    Dr Moshe Laudon

  39. Melatonin treatment of non-epileptic myoclonus in children

    Article • Developmental Medicine & Child Neurology, April 1999, Wiley

    Dr Moshe Laudon

  40. Rapid reversal of tolerance to benzodiazepine hypnotics by treatment with oral melatonin: a case report

    Article • European Neuropsychopharmacology, May 1997, Elsevier

    Dr Moshe Laudon

  41. Endothelin-Induced Biphasic Response of Lactotrophs Cultured under Different Conditions

    Article • Neuroendocrinology, January 1992, Karger Publishers

    Dr Moshe Laudon

  42. Melatonin binding proteins identified in the rat brain by affinity labeling

    Article • FEBS Letters, August 1991, Wiley

    Dr Moshe Laudon

  43. Localization and Growth Hormone (GH)-Releasing Activity of Rat Testicular GH-Releasing Hormone-Like Peptide*

    Article • Endocrinology, November 1990, Endocrine Society

    Dr Moshe Laudon

  44. Prolactin-Releasing Factor: Cellular Origin in the Intermediate Lobe of the Pituitary*

    Article • Endocrinology, June 1990, Endocrine Society

    Dr Moshe Laudon

  45. Melatonin antagonist

    Article • International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology, January 1990, Elsevier

    Dr Moshe Laudon

  46. Ontogeny of Prolactin Releasing and Inhibiting Activities in the Posterior Pituitary of Male Rats

    Article • Neuroendocrinology, January 1989, Karger Publishers

    Dr Moshe Laudon

  47. Circadian variations in melatonin-binding sites in discrete areas of the male rat brain

    Article • FEBS Letters, May 1988, Wiley

    Dr Moshe Laudon

  48. Melatonin Receptors in Discrete Brain Areas of the Male Rat

    Article • Neuroendocrinology, January 1988, Karger Publishers

    Dr Moshe Laudon

  49. A novel melatonin antagonist affects melatonin-mediated processes in vitro and in vivo

    Article • European Journal of Pharmacology, April 1987, Elsevier

    Dr Moshe Laudon

  50. Impact of circulating estradiol on melatonin binding sites in discrete areas of the female rat brain

    Article • Brain Research, January 1987, Elsevier

    Dr Moshe Laudon

  51. Regulation of Melatonin’s Activity in the Female Rat Brain by Estradiol: Effects on Neurotransmitter Release and on Iodomelatonin Binding Sites

    Article • Neuroendocrinology, January 1987, Karger Publishers

    Dr Moshe Laudon

  52. Characterization of central melatonin receptors using 125 I-melatonin

    Article • FEBS Letters, March 1986, Wiley

    Dr Moshe Laudon

  53. Circadian Variations in the Inhibition of Dopamine Release from Adult and Newborn Rat Hypothalamus by Melatonin

    Article • Neuroendocrinology, January 1985, Karger Publishers

    Dr Moshe Laudon

  54. Inhibition by melatonin of dopamine release from rat hypothalamus: regulation of calcium entry

    Article • Brain Research, August 1983, Elsevier

    Dr Moshe Laudon

  55. Inhibition by Melatonin of Dopamine Release from Rat Hypothalamus in vitro: Variations with Sex and the Estrous Cycle

    Article • Neuroendocrinology, January 1983, Karger Publishers

    Dr Moshe Laudon

  56. Plasminogen activator is enriched in the synaptosomal plasma membranes

    Article • Brain Research, September 1982, Elsevier

    Dr Moshe Laudon

  57. Inhibition of dopamine release by melatonin: regional distribution in the rat brain

    Article • Brain Research, August 1982, Elsevier

    Dr Moshe Laudon

  58. Dopamine release induced by electrical field stimulation of rat hypothalamus invitro: Inhibition by melatonin

    Article • Biochemical and Biophysical Research Communications, February 1982, Elsevier

    Dr Moshe Laudon